The White House cited data showing brand-name drugs in the United States are up to three times more expensive than identical drugs in other developed nations.

Under the Inflation Reduction Act, medications with the same active ingredient will be treated as the same drug for price ...

Amphastar is undervalued (~71% upside), but lacks an economic moat and faces modest growth, so I favor a cautious gradual ...

India's Torrent Pharma reported a 20% jump in its first-quarter profit on Monday, driven by demand for drugs used to treat ...

Despite a new EU-US trade deal, tariffs on pharmaceuticals remain uncertain and unchanged for now, pending the outcome of a ...

ACADIA’s $1B+ 2025 revenue outlook is driven by NUPLAZID and DAYBUE, with ACP-101 offering optional upside despite risks.

Untangling the sprawling, global supply chain will be complicated and expensive, and could inadvertently compete with other ...

Telix Pharmaceuticals Limited (NASDAQ:TLX) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds.

Kennedy's criticism largely stems from his belief that modern medicine and mainstream science are part of a global conspiracy to generate pharmaceutical profits.

The death toll from the explosion and fire at Sigachi Industries’ SIGC.NS chemical factory in southern India has risen to at least 39, officials said on Tuesday, forcing the supplier of pharma ...

Explosion at pharmaceutical factory in southern India kills at least 40 The death toll is expected to rise as authorities search the rubble of a Sigachi Industries plant in the state of Telangana.

Incyte shares rose Thursday after the drugmaker named Bill Meury its new CEO, effective immediately, to replace the retiring Hervé Hoppenot.